Home / Market News / $JAZZ
benzinga Corporate Catalyst Impact 55/100 ● neutral

Jim Cramer Gives Green Light To This Health Care Stock

Oct 12, 2026, 11:39 AM UTC · Primary ticker $JAZZ

This filing summarizes Jim Cramer's 'Mad Money Lightning Round' recommendations on several stocks. He expressed a positive view on Jazz Pharmaceuticals, a negative view on Apple Hospitality REIT and Corteva, and a neutral-to-curious stance on Onto Innovation and EchoStar. The market impact is moderate as it reflects a single analyst's opinion, albeit a prominent one, rather than a fundamental corporate event.

This filing details Jim Cramer's stock picks and pans from his 'Mad Money Lightning Round.' Cramer gave a 'yes' to Jazz Pharmaceuticals (JAZZ), citing its profitability, which could provide a short-term boost for the stock. Conversely, he advised against Apple Hospitality REIT (APLE) due to rising interest rates and Corteva (CTVA), favoring Vylor (VYLR) instead, which could put selling pressure on APLE and CTVA. His comments on Onto Innovation (ONTO) and EchoStar (ECHO) were more nuanced, suggesting further review or acknowledging potential catalysts like a SpaceX bid for ECHO. For traders, the immediate opportunity lies in potential short-term price movements based on Cramer's influence, particularly for JAZZ, APLE, and CTVA. The key risk is that Cramer's recommendations are often short-lived catalysts and may not reflect long-term fundamental value.

$JAZZ positive Cramer's positive recommendation
$APLE negative Cramer's negative recommendation due to interest rates
$CTVA negative Cramer prefers VYLR over CTVA
$ONTO neutral Cramer to take a 'harder look'
$ECHO neutral Cramer notes potential SpaceX bid
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.